{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:37:35Z","timestamp":1713933455612},"reference-count":55,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2023.1680","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T09:15:01Z","timestamp":1698052501000},"source":"Crossref","is-referenced-by-count":3,"title":["Molecular landscape of the <i>JAK2<\/i> gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil"],"prefix":"10.3892","volume":"19","author":[{"given":"Dania","family":"Torres","sequence":"first","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Barbosa Alves","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miliane","family":"Ara\u00fajo de Sousa","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanessa","family":"Laranjeira","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhemerson","family":"Paes","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erycka","family":"Alves","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Cant\u00e9","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson","family":"Costa","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Malheiro","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ros\u00e2ngela","family":"Abreu","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leny","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Fraiji","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Silva","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucivana","family":"Mour\u00e3o","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a","family":"Tarrag\u00f4","sequence":"additional","affiliation":[{"name":"Post\u2011graduate Program in Sciences Applied to Hematology, University of Amazonas State, Manaus, Amazonas State 69850\u2011001, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"issue":"15","key":"key20231117110147_b1-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: Document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J"},{"key":"key20231117110147_b2-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"key20231117110147_b3-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jaut.2017.06.010","article-title":"Inflammation and myeloproliferative neoplasms","volume":"85","author":"Lussana","year":"2017","journal-title":"J Autoimmun"},{"key":"key20231117110147_b4-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1182\/blood.2020006510","article-title":"Clonal hematopoiesis: Mechanisms driving dominance of stem cell clones","volume":"136","author":"Challen","year":"2020","journal-title":"Blood"},{"issue":"287","key":"key20231117110147_b5-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00287","article-title":"\u2018Do we know jack\u2019 about JAK? A closer look at JAK\/STAT signaling pathway","volume":"8","author":"Bousoik","year":"2018","journal-title":"Front Oncol"},{"issue":"321","key":"key20231117110147_b6-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00321","article-title":"The role of new technologies in myeloproliferative neoplasms","volume":"9","author":"Palumbo","year":"2019","journal-title":"Front Oncol"},{"key":"key20231117110147_b7-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N Engl J Med"},{"key":"key20231117110147_b8-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ajh.24221","article-title":"Myeloproliferative neoplasms: A decade of discoveries and treatment advances","volume":"91","author":"Tefferi","year":"2016","journal-title":"Am J Hematol"},{"key":"key20231117110147_b9-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"key20231117110147_b10-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1182\/asheducation-2014.1.268","article-title":"How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?","volume":"2014","author":"Chen","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"361","key":"key20231117110147_b11-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00361","article-title":"Mechanistic insights into regulation of JAK2 tyrosine kinase","volume":"8","author":"Hubbard","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20231117110147_b12-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/ccr3.2720","article-title":"Diagnosis of exon 12-positive polycythemia vera rescued by NGS","volume":"8","author":"Geay","year":"2020","journal-title":"Clin Case Rep"},{"key":"key20231117110147_b13-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph15020160","article-title":"JAK2 in myeloproliferative neoplasms: Still a protagonist","volume":"160","author":"Bader","year":"2022","journal-title":"Pharmaceuticals (Basel) 15:"},{"key":"key20231117110147_b14-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"key20231117110147_b15-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1007\/s00432-022-04327-0","article-title":"JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome","volume":"149","author":"Kandu\u0142a","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20231117110147_b16-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/10245332.2016.1267830","article-title":"Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms","volume":"22","author":"Hu","year":"2017","journal-title":"Hematology"},{"key":"key20231117110147_b17-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ajh.21338","article-title":"Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence and JAK 2 V617F allele burden","volume":"84","author":"Arellano-Rodrigo","year":"2009","journal-title":"Am J Hematol"},{"key":"key20231117110147_b18-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1111\/ijlh.13090","article-title":"A novel JAK2 R564* variant in a patient with thrombocytosis","volume":"42","author":"Villanueva","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"key20231117110147_b19-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ijlh.12425","article-title":"Detection of mutations in JAK2 exons 12-15 by Sanger sequencing","volume":"38","author":"Alghasham","year":"2016","journal-title":"Int J Lab Hematol"},{"issue":"2194","key":"key20231117110147_b20-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082194","article-title":"Next generation sequencing in MPNs. Lessons from the past and prospects for use as predictors of prognosis and treatment responses","volume":"12","author":"Skov","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20231117110147_b21-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"12367","DOI":"10.2147\/OTT.S287944","article-title":"Impact of mutational profile on the management of myeloproliferative neoplasms: A short review of the emerging data","volume":"13","author":"Loscocco","year":"2020","journal-title":"Onco Targets Ther"},{"key":"key20231117110147_b22-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/1076029618779136","article-title":"Association of genetic variability in selected genes in patients with deep vein thrombosis and platelet hyperaggregability","volume":"24","author":"Sokol","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"key20231117110147_b23-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1751-553X.2011.01386.x","article-title":"Association of Janus kinase 2 (JAK2) polymorphisms with acute leukemia susceptibility","volume":"34","author":"Zhong","year":"2012","journal-title":"Int J Lab Hematol"},{"issue":"e64628","key":"key20231117110147_b24-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064628","article-title":"Janus kinase 2 polymorphisms are associated with risk in patients with gastric cancer in a Chinese population","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"key20231117110147_b25-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00277-018-3499-y","article-title":"Next-generation sequencing for JAK2 mutation testing: Advantages and pitfalls","volume":"98","author":"Maslah","year":"2019","journal-title":"Ann Hematol"},{"key":"key20231117110147_b26-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3892\/or.2013.2455","article-title":"Search for mutations in signaling pathways in head and neck squamous cell carcinoma","volume":"30","author":"De Carvalho","year":"2013","journal-title":"Oncol Rep"},{"key":"key20231117110147_b27-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.humimm.2015.01.011","article-title":"Association of TNF-1031 C\/C as a potential protection marker for leprosy development in Amazonas state patients, Brazil. Hum","volume":"76","author":"Silva","year":"2015","journal-title":"Immunol"},{"key":"key20231117110147_b28-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/s0076-6879(80)65044-7","article-title":"Fractionation of DNA fragments by polyethylene glycol induced precipitation","volume":"65","author":"Lis","year":"1980","journal-title":"Methods Enzymol"},{"issue":"1346","key":"key20231117110147_b29-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/19.6.1346","article-title":"Precipitation of DNA by polyethylene glycol and ethanol","volume":"19","author":"Paithankar","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"key20231117110147_b30-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/ijlh.12380","article-title":"JAK2 46\/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Brazilian patients","volume":"37","author":"Macedo","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"key20231117110147_b31-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bcmd.2015.12.005","article-title":"Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients","volume":"57","author":"Macedo","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"key20231117110147_b32-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1089\/gtmb.2011.0272","article-title":"JAK2 V617F mutation prevalence in myeloproliferative neoplasms in Pernambuco, Brazil","volume":"16","author":"da Silva","year":"2012","journal-title":"Genet Test Mol Biomarkers"},{"key":"key20231117110147_b33-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.3324\/haematol.2019.229039","article-title":"Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?","volume":"104","author":"Hasselbalch","year":"2019","journal-title":"Haematologica"},{"issue":"102377","key":"key20231117110147_b34-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2019.102377","article-title":"The role of a low erythropoietin level in the diagnosis of JAK2 exon 12-mutated polycythemia vera","volume":"80","author":"Langabeer","year":"2020","journal-title":"Blood Cells Mol Dis"},{"key":"key20231117110147_b35-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.3324\/haematol.2018.215582","article-title":"Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses","volume":"105","author":"Maslah","year":"2020","journal-title":"Haematologica"},{"key":"key20231117110147_b36-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.2147\/CMAR.S245928","article-title":"The neutrophil to lymphocyte and lymphocyte to monocyte ratios as new prognostic factors in hematological malignancies-a narrative review","volume":"12","author":"Stefaniuk","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"2493","key":"key20231117110147_b37-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12102493","article-title":"Prognostic role of cell blood count in chronic myeloid neoplasm and acute myeloid leukemia and its possible implications in hematopoietic stem cell transplantation","volume":"12","author":"Mulas","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"key20231117110147_b38-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1158\/1055-9965.EPI-09-0353","article-title":"Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Epidemiol","volume":"18","author":"Vannucchi","year":"2009","journal-title":"Biomarkers Prev"},{"key":"key20231117110147_b39-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1111\/bjh.16624","article-title":"Analysis of saliva samples and cluster of differentiation 3 (CD3)+ lymphocytes as a source of germline DNA in myeloproliferative neoplasms","volume":"189","author":"Garcia-Gisbert","year":"2020","journal-title":"Br J Haematol"},{"key":"key20231117110147_b40-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1590\/1806-9282.20200778","article-title":"The evaluation of patients with essential thrombocythemia in terms of risk of thrombosis","volume":"67","author":"Sunu","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"e0218040","key":"key20231117110147_b41-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218040","article-title":"Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with \u03b2S haplotype and \u03b1-thalassemia","volume":"14","author":"Yahou\u00e9d\u00e9hou","year":"2019","journal-title":"PLoS One"},{"issue":"115","key":"key20231117110147_b42-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1997.01900010125021","article-title":"The good, the bad, and the ugly","volume":"123","author":"Davidson","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key20231117110147_b43-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/ejh.12759","article-title":"Influence of platelet and white blood cell counts on major thrombosis-analysis from a patient registry in essential thrombocythemia","volume":"97","author":"Buxhofer-Ausch","year":"2016","journal-title":"Eur J Haematol"},{"issue":"18","key":"key20231117110147_b44-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0242-9","article-title":"Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): Analysis from the German SAL-MPN-registry","volume":"9","author":"Kaifie","year":"2016","journal-title":"J Hematol Oncol"},{"key":"key20231117110147_b45-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1161\/ATVBAHA.120.314760","article-title":"Platelet dysfunction and thrombosis in JAK2V617F-mutated primary myelofibrotic mice","volume":"40","author":"Matsuura","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2634853520978210","key":"key20231117110147_b46-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.1177\/2634853520978210","article-title":"The essential thrombocythemia in 2020: What we know and where we still have to dig deep","volume":"13","author":"Accurso","year":"2020","journal-title":"Clin Med Insights Blood Disord"},{"issue":"83","key":"key20231117110147_b47-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-017-0944-z","article-title":"Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms","volume":"34","author":"Chang","year":"2017","journal-title":"Med Oncol"},{"key":"key20231117110147_b48-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1182\/blood-2015-07-661835","article-title":"Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms","volume":"127","author":"Milosevic Feenstra","year":"2016","journal-title":"Blood"},{"key":"key20231117110147_b49-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/gcc.22781","article-title":"Concomitant and noncanonical JAK2 and MPL mutations in JAK2V617F- and MPLW515 L-positive myelofibrosis","volume":"58","author":"Schulze","year":"2019","journal-title":"Genes Chromosom Cancer"},{"key":"key20231117110147_b50-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1182\/blood-2013-05-504555","article-title":"Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors","volume":"123","author":"Marty","year":"2014","journal-title":"Blood"},{"key":"key20231117110147_b51-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1182\/blood-2012-12-473777","article-title":"A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis","volume":"123","author":"Etheridge","year":"2014","journal-title":"Blood"},{"issue":"1013","key":"key20231117110147_b52-BR-19-6-01680","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031013","article-title":"Insights into the potential mechanisms of JAK2V617F somatic mutation contributing distinct phenotypes in myeloproliferative neoplasms","volume":"23","author":"Gou","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20231117110147_b53-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1042\/BJ20090615","article-title":"A regulating role of the JAK2 FERM domain in hyperactivation of JAK2(V617F)","volume":"426","author":"Zhao","year":"2010","journal-title":"Biochem J"},{"key":"key20231117110147_b54-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1182\/blood-2016-02-698951","article-title":"Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia","volume":"128","author":"Kapralova","year":"2016","journal-title":"Blood"},{"key":"key20231117110147_b55-BR-19-6-01680","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1182\/blood-2016-04-711283","article-title":"Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia vera","volume":"128","author":"Lanikova","year":"2016","journal-title":"Blood"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T09:02:16Z","timestamp":1700211736000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2023.1680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10,23]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2023.1680","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"article-number":"98"}}